Protect yourself with information
Every year approximately 6.2 million people are affected with Human Papilloma Virus (HPV), the most common sexually transmitted infection in the United States, and over half of all sexually active men and women become infected at some time in their lives, according to the Center for Disease Control.
On June 8, 2006, the Food and Drug Administration (FDA) announced their approval of Gardasil; the first vaccine developed to prevent cervical cancer, precancerous genital lesions and genital warts due to HPV types six, 11, 16 and 18 for females 9-26 years of age.
“On an average 9,710 new cases of cervical cancer and 3,700 deaths attributed to it in the United States every year. Worldwide, cervical cancer is the second most common cancer in women; and is estimated to cause over 470,000 new cases and 2333,000 deaths each year,” said the FDA Web site.
“HPV is a virus that is passed by skin-to skin contact,” Planned Parenthood of the Rocky Mountains said. “Gardasil is a vaccine that protects against the diseases caused by HPV types six, 11, 16 and 18. HPV types 16 and 18 cause seventy percent of all cervical cancers, and HPV types six and 11 cause ninety percent of genital warts.”
It’s best for the vaccine to be administered before the onset of sexual activity, but young women who are sexually active should still be vaccinated. Three visits are needed for the HPV vaccine.
The vaccine is not a treatment or cure for HPV; however, if a person has one type of HPV it may protect them from the other types.
Researchers agree to lower the risk of contacting HVP a person can choose not to have sex, limit the number of partners and choose a partner who has had no sex or few sex partners.
The studies are new and at this time it is not known how long the vaccine will protect a person or if booster will be needed in a couple of years.
All women should have routine Pap tests. Consult your physician about the vaccine or contact Planned Parenthood of Rocky Mountains located at 995 w. US Highway 50 Pueblo Colo. which is currently offering the Cervical Cancer Vaccine. They may be reached at 719-545-0246 or online
According to the FDA Web site, “Gardasil is manufactured by Merck & Co., Inc., of Whitehouse Station, NJ. The manufacture has agreed conduct several studies following licensure, including additional studies to further evaluate general safety and long-term effectiveness. The manufacturer will also monitor the pregnancy outcomes of women who receive Gardasil while unknowingly pregnant. Also, the manufacturer has an ongoing study to evaluate the safety and effectiveness of Gardasil in males.”
The vaccine, called Gardasil, mimics the disease and creates resistance. It is NOT a live or a dead virus. It prevents infection with HPV types six, 11, 16 and 18.
The safety of the vaccine was evaluated in approximately 11,000 individuals and the most adverse experience in study participants who receiver Gardasil included mild or moderate local reactions, such as pain or tenderness at the site of injection.
For more Information consult:
- Center for Disease Control and Prevention Your Online Source for Credible Health Information CDC
- Wikipedia The Free Encyclopedia
- National Institute of Allergy and Infectious Diseases
- Engender Health
- National Women’s Health Resource Center
- Fact sheet
National cancer Institute